为什么针对微生物组的临床试验往往无法支持健康主张:关于益生菌和翻译设计的评论
Raul de Jesus Cano1, Gissel García Menéndez2
1Chauvell, LLC, San Luis Obispo, CA 93405, USA.
Microorganisms
|February 27, 2026
概括
微生物组干预的临床试验经常显示微生物组变化,但缺乏强有力的健康证据. 改进试验设计,专注于宿主结果和管理混因素是可重现结果的关键.
科学领域:
- 微生物组研究的研究.
- 临床试验的设计
- 翻译科学是翻译的科学.
背景情况:
- 益生菌和微生物干预正在迅速扩大,有许多人体临床试验.
- 尽管报告了微生物组的变化,但很少有研究为健康声明或可重现的结果提供了令人信服的证据.
研究的目的:
- 检查微生物组介导干预的临床验证中常见的失败模式.
- 提出改善微生物组研究可再生性和临床相关性的策略.
主要方法:
- 分析试验设计和解释中常见的缺陷.
- 检查过度依赖描述性微生物组指标作为替代终点的审查.
- 讨论诸如饮食,抗生素和药物等混因素.
主要成果:
- 缺陷包括使用描述性微生物组指标作为替代终点和错误的结果措施.
- 混因子的控制不足和设计不足掩盖了真正的生物信号.
- 将微生物组视为机械媒介,而不是临床终点,可以获得更强有力的证据.
结论:
- 试验需要前性地定义与生物机制相关的权利要求,并优先考虑与宿主相关的结果.
- 整合微生物组测量对于机械学可信度至关重要.
- 阶段性开发,有纪律的统计规划和透明的混管理提高了可重复性.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Preclinical Development: Overview
6.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.2K
Bioavailability Study Design: Healthy Subjects Versus Patients
192
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192


